Can a nation-wide e-cohort of ADHD and ASD in childhood be established using Welsh routinely available datasets?
child & adolescent psychiatry
community child health
depression & mood disorders
mental health
substance misuse
suicide & self-harm
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
21 08 2023
21 08 2023
Historique:
medline:
23
8
2023
pubmed:
22
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
We investigated the feasibility and validity of establishing a nationwide e-cohort of individuals with a diagnosis of attention deficit hyperactivity disorder (ADHD) and/or autism spectrum disorder (ASD) for future longitudinal research. Individuals with a childhood diagnosis of ADHD/ASD as recorded on routinely available healthcare datasets were compared with matched controls and a sample of directly assessed individuals with ADHD. This study used data from the Welsh Secure Anonymised Information Linkage Databank in Wales, UK. Routinely collected data from primary care, emergency department and hospital admissions were linked at person level. All individuals in Wales, UK born between 1 January 1991 and 31 December 2000. Individuals with a recorded diagnosis of ADHD and/or ASD by age 18 years were identified using International Classification of Diseases, 10th Revision and National Health Service (NHS) READ codes and matched to 3 controls each and 154 individuals with ADHD recruited from an established research study. Recorded service use for anxiety and depression, alcohol and drug use and self-harm including emergency department use in young adulthood (age 16-25 years). 7726 individuals had a recorded diagnosis of ADHD (80% male) and 5001 of ASD (79% male); 1.4% and 0.9% of the population, respectively. Cox's regression analyses showed ADHD was associated with increased risks of anxiety/depression (HR: 2.36, 95% CI: 2.20 to 2.53), self-harm (HR: 5.70, 95% CI: 5.07 to 6.40), alcohol (HR: 3.95, 95% CI: 3.42 to 4.56), drug use (HR: 5.88, 95% CI: 5.08 to 6.80) and emergency department service use (HR: 1.36, 95% CI: 1.31 to 1.41). Those with ASD were at increased risk of anxiety/depression (HR: 2.11, 95% CI: 1.91 to 2.34), self-harm (HR: 2.93, 95% CI: 2.45 to 3.50) and drug use (HR: 2.21, 95% CI: 1.66 to 2.95) but not alcohol use. The ADHD e-cohort were similar to the directly assessed cohort. Our identification strategy demonstrated the feasibility of establishing a large e-cohort of those with ADHD/ASD with expected patterns of poorer early adult outcomes, demonstrating a valid method of identifying large samples for future longitudinal studies without selective attrition.
Identifiants
pubmed: 37604636
pii: bmjopen-2023-071851
doi: 10.1136/bmjopen-2023-071851
pmc: PMC10445352
doi:
Substances chimiques
Ethanol
3K9958V90M
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e071851Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: AT is on the executive board of the UK Charity ADHD Foundation (unpaid). All salary comes from Cardiff University only. KL has received a speaker’s fee from Medice on a topic unrelated to this research. All other authors declare no conflicts of interest.
Références
J Child Psychol Psychiatry. 2000 Jul;41(5):645-55
pubmed: 10946756
J Am Acad Child Adolesc Psychiatry. 2019 Apr;58(4):412-422.e3
pubmed: 30768399
J Am Acad Child Adolesc Psychiatry. 2011 Jan;50(1):9-21
pubmed: 21156266
Autism. 2022 Aug;26(6):1499-1508
pubmed: 34841925
J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):34-46.e2
pubmed: 24342384
Lancet Psychiatry. 2017 Apr;4(4):339-346
pubmed: 27979720
BMC Med Inform Decis Mak. 2009 Jan 16;9:3
pubmed: 19149883
Arch Dis Child. 2020 Apr;105(4):347-354
pubmed: 31611193
J Child Adolesc Psychopharmacol. 2013 Sep;23(7):432-9
pubmed: 24015896
Lancet. 2015 May 30;385(9983):2190-6
pubmed: 25726514
MMWR Surveill Summ. 2018 Apr 27;67(6):1-23
pubmed: 29701730
Psychol Med. 2019 Mar;49(4):559-572
pubmed: 30178724
JAMA Pediatr. 2021 Feb 1;175(2):e205371
pubmed: 33394019
Psychol Med. 1995 Jul;25(4):739-53
pubmed: 7480451
Addiction. 2020 Jul;115(7):1368-1377
pubmed: 31803957
J Child Psychol Psychiatry. 2015 Mar;56(3):370-93
pubmed: 25496340
JAMA Psychiatry. 2018 Aug 1;75(8):835-843
pubmed: 29898212
Autism Res. 2012 Jun;5(3):160-79
pubmed: 22495912
Br J Psychiatry. 2020 Dec;217(6):717-724
pubmed: 32744207
BMC Psychiatry. 2014 May 07;14:133
pubmed: 24884622
J Am Acad Child Adolesc Psychiatry. 2003 Oct;42(10):1203-11
pubmed: 14560170
Lancet. 2018 Aug 11;392(10146):508-520
pubmed: 30078460
Am J Epidemiol. 2016 Jun 15;183(12):1149-58
pubmed: 27188935
BMJ Open. 2013 Oct 16;3(10):e003219
pubmed: 24131525
Neuropsychiatr Dis Treat. 2018 May 07;14:1149-1161
pubmed: 29765219
Int J Epidemiol. 2014 Dec;43(6):1815-24
pubmed: 25355726
Eur Child Adolesc Psychiatry. 2013 Jun;22(6):369-77
pubmed: 23385540
J Autism Dev Disord. 2020 Oct;50(10):3561-3574
pubmed: 31655964
Br J Psychiatry. 2010 Mar;196(3):235-40
pubmed: 20194547
BMC Med Inform Decis Mak. 2016 Mar 15;16:35
pubmed: 26979325
Lancet. 2016 Mar 19;387(10024):1240-50
pubmed: 26386541
Int J Epidemiol. 2018 Aug 1;47(4):1207-1216
pubmed: 29800128
Br J Psychiatry. 2009 Sep;195(3):249-56
pubmed: 19721116
Int J Epidemiol. 2014 Apr;43(2):434-42
pubmed: 24464188
Acta Paediatr. 2005 Jan;94(1):2-15
pubmed: 15858952